SEC Form 4
Imunon, Inc. (IMNN) insider trading
In the 12 months to Oct 26, 2026, one IMNN insider reported open-market sales of $38.2K across 6 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $38.2K
- 6 filings · 1 insider
- Open-market purchases
- $0
- 0 filings
Who traded IMNN, and when
- Sale
IMNN daily close from Oct 27, 2025 to Oct 26, 2026, between $0.99 and $4.72, last $1.22. 6 sale and 0 purchase filings by 1 insider, marked at their filing dates. Susan Eylward, General Counsel and Corp Sec: sold $38.2K across 6 filings, first filed Jun 29, 2026, last Sep 1, 2026.
Largest mark · tap a row for others
Susan Eylward · General Counsel and Corp Sec
Sale $20,674
11,800 shares at $1.75 avg
Filed Jun 29, 2026
Close on filing date $1.80
Susan Eylward · General Counsel and Corp Sec
General Counsel and Corp Sec
$38.2K soldOpen-market trades
6 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Susan Eylward | General Counsel and Corp Sec | $38.2K | — | 6 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Susan Eylward General Counsel and Corp Sec | Sale | 2,525 | $1.56 | $3.9K | 2,896 | |
traded | Susan Eylward General Counsel and Corp Sec | Sale | 2,449 | $1.63 | $4.0K | 2,896 | |
traded | Susan Eylward General Counsel and Corp Sec | Sale | 2,541 | $1.57 | $4.0K | 2,896 | |
traded | Susan Eylward General Counsel and Corp Sec | Sale | 2,150 | $1.78 | $3.8K | 2,896 | |
traded | Susan Eylward General Counsel and Corp Sec | Sale | 920 | $1.88 | $1.7K | 2,896 | |
traded | Susan Eylward General Counsel and Corp Sec | Sale | 11,800 | $1.75 | $20.7K | 2,896 |
GET /stocks/filings/vX/form-4?tickers=IMNN&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"IMNN"
],
"issuer_cik": "0000749647",
"owner_cik": "0002039135",
"accession_number": "0001437749-26-029405",
"form_type": "4",
"filing_date": "2026-09-01",
"period_of_report": "2026-08-28",
"issuer_name": "Imunon, Inc.",
"issuer_trading_symbol": "IMNN",
"owner_name": "Eylward Susan",
"is_officer": true,
"officer_title": "General Counsel and Corp Sec",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-31",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2525,
"transaction_price_per_share": 1.5643,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 2896,
"transaction_value": 3949.8575,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "Reflects a weighted average sale price of $1.5643 per share, at prices ranging from $1.55 to $1.58 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price."
}
]
},
{
"tickers": [
"IMNN"
],
"issuer_cik": "0000749647",
"owner_cik": "0002039135",
"accession_number": "0001437749-26-028184",
"form_type": "4",
"filing_date": "2026-08-17",
"period_of_report": "2026-08-14",
"issuer_name": "Imunon, Inc.",
"issuer_trading_symbol": "IMNN",
"owner_name": "Eylward Susan",
"is_officer": true,
"officer_title": "General Counsel and Corp Sec",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-08-17",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 2449,
"transaction_price_per_share": 1.6303,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 2896,
"transaction_value": 3992.6047000000003,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F2",
"description": "Reflects a weighted average sale price of $1.6303 per share, at prices ranging from $1.61 to $1.655 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 47 records
- Grants and awards47 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Imunon, Inc.'s CEO sold stock?
No. Stacy Lindborg (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is IMNN’s insider data?
These are IMNN Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track IMNN insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for IMNN every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.